Sifuvirtide

西夫韦肽

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameSifuvirtide
Drug Alias NameSifuvirtide injectionSifuvirtide microbicideFS-0101SFT
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionTransmembrane glycoprotein gp41 inhibitors
TargetsTransmembrane glycoprotein gp41
Therapy Area/IndicationsAcquired Immunodeficiency SyndromeHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesTianjin Fusogen Pharmaceuticals Inc
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesTianjin Fusogen Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsAcquired Immunodeficiency Syndrome
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A